Introduction of ventilators for neonates were one of the time changing and life-saving innovations that manufacturers developed to provide life-saving support for neonates having respiratory ailments. With advances in medical technologies, such as replacement surfactant therapy and administration of antepartum corticosteroids, neonatal ventilators have improved the infant survival quotient, specifically for preterm infants that suffer from immature functioning of lungs.
NICUs to Present Lucrative Growth Opportunities
Neonatal Intensive Care Units (NICUs), particularly developed for providing extreme care for neonates have witnessed an increase in the number of admissions. In United Kingdom, around 95,000 babies are born in NICUs owing to higher preterm births in the country. In addition, with the growing preterm birth statistics, the number of NICUs have also increased with higher intake capacity and enhanced patient care facilities. This is expected to auger well for the neonatal ventilator market with respect to high volume sales of the product in NICUs across various regions.
To gain more valuable insights, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=758
Lung Injuries Associated With Neonatal Ventilators – a Major Challenge
Neonatal ventilators used for supporting respiratory function of the infant can result in lung injuries owing to excess airway pressure, flow, tidal volume, inflammatory and infection mediators coupled with recurring closing and opening of alveoli. Lungs of neonates being smaller in size and not completely developed, their injuries can lead to critical complications such as BPD (Bronchopulmonary Dysplasia), even death owing to respiratory failure. This has challenged the use of neonatal ventilators and is expected to hinder the growth of the neonatal ventilator market.